Literature DB >> 20127226

Gene expression signatures in the peripheral blood after radiosurgery of human cerebral arteriovenous malformations.

Angelika Zabel-du Bois1,2,3, Mechthild Wagner-Ecker4, Stefanie Milker-Zabel5, Christian Schwager4, Ute Wirkner4, Jürgen Debus5, Amir Abdollahi4,5,6, Peter E Huber4.   

Abstract

PURPOSE: To unravel biological mechanisms potentially resulting in the obliteration process after radiosurgery (RS) of human cerebral arteriovenous malformations (AVMs) by investigating molecular signatures on the transcriptomic level in peripheral blood of patients. PATIENTS AND METHODS: Venous blood samples were obtained at definite points of time before and after RS. The samples were tested for radiation-induced changes regarding biological markers (mRNA) using cDNA and oligo-microarray technology. The corresponding expression profiles were correlated with clinical data and obliteration signs in radiologic imaging.
RESULTS: The proof of principle that RS outcome can be successfully correlated with transcriptomics of cellular blood components as disease parameter was demonstrated. The authors identified 76 differentially regulated genes (p < 0.001) after RS. Interestingly, in particular genes with known roles in anti-angiogenic and pro-coagulative pathways were identified as potentially relevant. In particularly, the authors found a significant downregulation of neuropilin-2, protein C inhibitor and cyclin-dependent kinase 6. They also found that low pretreatment blood mRNA levels of TLR4 (toll-like receptor 4) and STAT3 (signal transducer and activator of transcription 3) correlated with fast obliteration of AVMs.
CONCLUSION: The authors report on a novel technique for molecular biological analysis of blood from patients with cerebral AVM treated with RS. Differential regulation of genes in peripheral blood was successfully correlated with RS and time to obliteration of AVMs. The identified genes indicate a potential new methodology to monitor RS, which may result in an individualized therapy and optimized follow-up.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127226     DOI: 10.1007/s00066-010-2034-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  34 in total

1.  Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected].

Authors:  Z Gluzman-Poltorak; T Cohen; Y Herzog; G Neufeld
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

2.  A proposed radiosurgery-based grading system for arteriovenous malformations.

Authors:  Bruce E Pollock; John C Flickinger
Journal:  J Neurosurg       Date:  2002-01       Impact factor: 5.115

Review 3.  The role of STATs in transcriptional control and their impact on cellular function.

Authors:  J Bromberg; J E Darnell
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

4.  Clinical outcome of radiosurgery for cerebral arteriovenous malformations.

Authors:  L Steiner; C Lindquist; J R Adler; J C Torner; W Alves; M Steiner
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

5.  A proposed grading system for arteriovenous malformations.

Authors:  R F Spetzler; N A Martin
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

6.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

7.  TableButler - a Windows based tool for processing large data tables generated with high-throughput methods.

Authors:  Christian Schwager; Ute Wirkner; Amir Abdollahi; Peter E Huber
Journal:  BMC Bioinformatics       Date:  2009-07-29       Impact factor: 3.169

8.  Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade.

Authors:  Maximilian Niyazi; Patrizia Marini; Peter T Daniel; Robin Humphreys; Verena Jendrossek; Claus Belka
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

9.  Patient outcomes after arteriovenous malformation radiosurgical management: results based on a 5- to 14-year follow-up study.

Authors:  Bruce E Pollock; Deborah A Gorman; Robert J Coffey
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

10.  Transcriptional network governing the angiogenic switch in human pancreatic cancer.

Authors:  Amir Abdollahi; Christian Schwager; Jörg Kleeff; Irene Esposito; Sophie Domhan; Peter Peschke; Kai Hauser; Philip Hahnfeldt; Lynn Hlatky; Jürgen Debus; Jeffrey M Peters; Helmut Friess; Judah Folkman; Peter E Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

View more
  5 in total

1.  Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas.

Authors:  M Fuetsch; F El Majdoub; M Hoevels; R P Müller; V Sturm; M Maarouf
Journal:  Strahlenther Onkol       Date:  2012-04       Impact factor: 3.621

2.  Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90α.

Authors:  L Stingl; N Niewidok; N Müller; M Selle; C S Djuzenova; M Flentje
Journal:  Strahlenther Onkol       Date:  2012-03-24       Impact factor: 3.621

3.  A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).

Authors:  Seyer Safi; Philipp Beckhove; Arne Warth; Axel Benner; Falk Roeder; Stefan Rieken; Juergen Debus; Hendrik Dienemann; Hans Hoffmann; Peter E Huber
Journal:  BMC Cancer       Date:  2015-12-19       Impact factor: 4.430

4.  Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy.

Authors:  Maximilian Knoll; Maria Waltenberger; Jennifer Furkel; Ute Wirkner; Aoife Ward Gahlawat; Ivana Dokic; Christian Schwager; Sebastian Adeberg; Stefan Rieken; Tobias Kessler; Felix Sahm; Laila König; Christel Herold-Mende; Stephanie E Combs; Jürgen Debus; Amir Abdollahi
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

5.  The impact of tumor metabolic activity assessed by 18F-FET amino acid PET imaging in particle radiotherapy of high-grade glioma patients.

Authors:  Maria Waltenberger; Jennifer Furkel; Manuel Röhrich; Patrick Salome; Charlotte Debus; Bouchra Tawk; Aoife Ward Gahlawat; Andreas Kudak; Matthias Dostal; Ute Wirkner; Christian Schwager; Christel Herold-Mende; Stephanie E Combs; Laila König; Jürgen Debus; Uwe Haberkorn; Amir Abdollahi; Maximilian Knoll
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.